Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

eneral and the Government Accountability Office', with testimony from Small Business Administration Inspector General Mike Ware; and GAO Director of Financial Markets and Community Investment William Shear * Held via Cisco Webex and in Rm 2360, Rayburn House Office Building; 10:00 AM • House Oversight Committee

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

eneral and the Government Accountability Office', with testimony from Small Business Administration Inspector General Mike Ware; and GAO Director of Financial Markets and Community Investment William Shear * Held via Cisco Webex and in Rm 2360, Rayburn House Office Building; 10:00 AM EFTA00148936 • House Overs

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

eneral and the Government Accountability Office', with testimony from Small Business Administration Inspector General Mike Ware; and GAO Director of Financial Markets and Community Investment William Shear * Held via Cisco Webex and in Rm 2360, Rayburn House Office Building; 10:00 AM • House Oversight Committee